William Stilley

William Stilley is the current CEO of Adovate, where William focuses on developing molecules targeting adenosine receptors to improve human health. William is also a board member and Chair of Audit Committee at Avalon Globocare Corp, a leader in immune effector cell therapy and regenerative therapeutics. Additionally, William is a board member at the Virginia Biotechnology Association. Previous roles include co-founding Purnovate, being a board member at Sysorex, and serving as CEO of Adial Pharmaceuticals. William has a strong background in business and strategy, with previous experience at Darden School of Business and PGxHealth. William holds an MBA from the University of Virginia Darden School of Business and a Bachelor's Degree in Commerce/Marketing from the University of Virginia.